Skip to main navigation Skip to search Skip to main content

Synthesis and biological evaluation of piperamide analogues as HDAC inhibitors

  • Yu Luo
  • , Hao Min Liu
  • , Ming Bo Su
  • , Li Sheng
  • , Yu Bo Zhou
  • , Jia Li*
  • , Wei Lu
  • *Corresponding author for this work
  • East China Normal University
  • CAS - Shanghai Institute of Materia Medica

Research output: Contribution to journalArticlepeer-review

Abstract

Two natural piperamides (piperlonguminine and refrofractamide A) and their derivatives were synthesized and evaluated for inhibitory activity against histone deacetylases, as well as the HCT-116 human colon cancer cell line. The preliminary structure activity relationship was discussed. Compounds featuring a hydroxamic acid moiety exhibited moderate HDAC activity and in vitro cytotoxicity.

Original languageEnglish
Pages (from-to)4844-4846
Number of pages3
JournalBioorganic and Medicinal Chemistry Letters
Volume21
Issue number16
DOIs
StatePublished - 15 Aug 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • HDAC
  • Piperlonguminine
  • Refrofractamide A

Fingerprint

Dive into the research topics of 'Synthesis and biological evaluation of piperamide analogues as HDAC inhibitors'. Together they form a unique fingerprint.

Cite this